Haiti sees first African swine fever outbreak in 37 years

Translate to Spanish or other 102 languages!

A pig pokes its nose through a fence in Harrisburg, Pa., in this January 2013 file photo. (The Patriot-News/Joe Hermitt)
A pig pokes its nose through a fence in Harrisburg, Pa., in this January 2013 file photo. (The Patriot-News/Joe Hermitt)

CTV NEWS – CHICAGO – Haiti has its first outbreak of the fatal pig virus African swine fever in 37 years, the World Organization for Animal Health said, fueling concerns about the disease’s spread in the Americas.

- Advertisement -

The organization, known as the OIE, said in a report on Monday that one backyard farm in Anse-à-Pitre, near Haiti’s border with the Dominican Republic, suffered an outbreak that began on Aug. 26.

Click the link to read the entire story:  https://www.ctvnews.ca/health/haiti-sees-first-african-swine-fever-outbreak-in-37-years-1.5594671

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recertified for Advanced Hip & Knee Replacements

DHR Health has once again earned The Joint Commission's Advanced Certification in Total Hip and Total Knee Replacement, reaffirming its commitment to providing high-quality, patient-centered orthopedic care to the Rio Grande Valley.

STHS Named to Newsweek’s America’s Greatest Midsize Workplaces for Women

The American workforce is more diverse than ever, with women helping lead that transformation. 

Dysfunctional, Not Missing, Immune Cells Explain Skin Cancer Risk in Immunosuppressed Patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

New Study Reveals Real-World Safety Findings for Latest Alzheimer’s Treatment

As new Alzheimer’s drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them, and whether they truly slow the disease outside tightly controlled studies.
- Advertisement -